Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
29.73
+0.29 (0.99%)
At close: Mar 9, 2026, 4:00 PM EDT
30.22
+0.49 (1.65%)
After-hours: Mar 9, 2026, 7:41 PM EDT

Enliven Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Net Income
-103.69-89.02-71.58-37.66-24.74
Upgrade
Depreciation & Amortization
0.260.320.30.220.12
Upgrade
Other Amortization
---1.74-
Upgrade
Loss (Gain) From Sale of Assets
0.110.01---
Upgrade
Loss (Gain) From Sale of Investments
-0.230.42-4.6--
Upgrade
Stock-Based Compensation
34.0220.1712.913.191.92
Upgrade
Other Operating Activities
0.35-0.550.31--
Upgrade
Change in Accounts Payable
0.820.81-2.250.411.73
Upgrade
Change in Other Net Operating Assets
-1.94-5.353.650.031.83
Upgrade
Operating Cash Flow
-70.3-73.19-61.27-32.08-19.13
Upgrade
Capital Expenditures
-0.16-0.04-0.15-0.61-0.19
Upgrade
Sale of Property, Plant & Equipment
0.21----
Upgrade
Investment in Securities
-173.9-36.83-148.26--
Upgrade
Other Investing Activities
-0.87---
Upgrade
Investing Cash Flow
-173.84-36-148.41-0.61-0.19
Upgrade
Issuance of Common Stock
219.08133.17243.590.590.69
Upgrade
Other Financing Activities
-0.22--9.3-2.39-1.71
Upgrade
Financing Cash Flow
218.87133.17234.29-1.8-1.02
Upgrade
Net Cash Flow
-25.2823.9824.61-34.49-20.34
Upgrade
Free Cash Flow
-70.46-73.24-61.42-32.69-19.33
Upgrade
Free Cash Flow Per Share
-1.24-1.56-1.73-10.46-2.47
Upgrade
Cash Income Tax Paid
-0.23---
Upgrade
Levered Free Cash Flow
-47.98-46.23-32.95-17.48-9.83
Upgrade
Unlevered Free Cash Flow
-47.98-46.23-32.95-17.48-9.83
Upgrade
Change in Working Capital
-1.12-4.541.40.443.57
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.